ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2196

Trajectories and Predictors of Fear-Avoidance in Persons with Rheumatoid Arthritis. a Longitudinal Observational Study

Christina H. Opava1, Annika Björk2, Alyssa B. Dufour1,3, Birgitta Nordgren1 and Ingrid Demmelmaier4, 1Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Huddinge, Sweden, 2Nacka Rehabilitation Center, Stockholm County Council, Nacka, Sweden, 3Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School & Beth Israel Deaconess Medical Center, Boston, MA, 4Neurobiology, Care Sciences & Society, Karolinska Institutet, Huddinge, Sweden

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: longitudinal studies, Pain and physical activity

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Epidemiology and Public Health - ARHP Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Trajectories and Predictors of Fear-Avoidance in Persons With Rheumatoid Arthritis. A Longitudinal Observational Study

 

Background/Purpose: Rheumatoid arthritis (RA) is a chronic, inflammatory disease with symptoms such as pain, severe fatigue, depression and activity limitation. Pain and activity limitation are known to increase the risk of developing fear-avoidance behavior but their associations with physical activity are not fully verified. RA is a chronic disease that people have to live with for many years but knowledge on how fear-avoidance develops over time is still scarce. The aim of the study was to identify and describe groups with different trajectories of fear-avoidance beliefs over 2 years and to identify predictors for each trajectory in people with RA.

Methods: A sample of 2569 people with RA (mean age 58, 77% women) was identified via the Swedish Rheumatology Quality Registers. They responded, at baseline and at 1-year and 2-year follow-ups, to a valid questionnaire on demographics (age, gender, number of children and adults in household, education, income) health-enhancing physical activity (HEPA, current and maintained), disease-related factors (co-morbidity, perceived health, pain, fatigue, activity limitation) and psychosocial matters (fear-avoidance beliefs, anxiety/depression and self-efficacy for exercise). Data were analyzed with k-means longitudinal cluster analysis to identify trajectories of fear-avoidance beliefs and multinomial logistic regression to identify predictors of each trajectory.  

Results: Three stable trajectories of fear-avoidance beliefs were identified from the cluster analysis; one with low (n = 1060) fear-avoidance beliefs, one with moderate (n = 1043) and one with high (n = 466). Predictors of stable high fear-avoidance beliefs, compared to low or moderate levels, were male gender, below average income, current physical activity below HEPA levels and high activity limitation. Additional predictors of high fear-avoidance beliefs compared to low were below-university education, high pain, moderate activity limitation and low self-efficacy for exercise (Table 1).

Conclusion: There are 3 stable trajectories of fear-avoidance behavior in people with RA. The strongest modifiable predictors of persistently high fear-avoidance beliefs are more pronounced activity limitation, pain, below HEPA levels and low self-efficacy for exercise. These factors are important to identify at an early stage in people with RA in order to develop strategies to prevent high fear-avoidance behavior. Table 1. Baseline predictors of trajectories with high (n = 466) vs low (n = 1060) and moderate (n = 1043) fear/avoidance beliefs. Odds ratios (OR) and 95% confidence intervals (CI). Bold figures indicate significant predictors (p < 0.01).  

Baseline predictors  

High vs low

OR (95% CI)

High vs moderate

OR (95% CI)

  Gender Women vs men

 

0.30 (0.22-0.41)

 

0.51 (0.39-0.67)

 

Education High school vs university

1.84 (1.29-2.62)

1.33 (0.96-1.85)

 

  Elementary school vs university  

1.99 (1.38-2.86)

1.34 (0.96-1.87)

Income Above vs below average

0.42 (0.31-0.57)

0.50 (0.38-0.65)

 

Current HEPA Yes vs no

0.54 (0.41-0.72)

0.70  (0.55-0.89)

 

Pain (VAS, 0-100)a >55 vs <30

2.58 (1.58-4.22)

1.22 (0.79-1.87)

 

Activity limitationa (HAQ, 0-3) >1.0 vs 0

7.14 (4.19-12.19)

2.11 (1.28-3.47)

  0.1-1.0 vs 0  

3.10 (2.01-4.78)

1.60 (1.04-2.48)

Anxiety/depression (EuroQoL, yes/some/no)   Some vs no

1.50 (1.13-2.01)

1.31 (1.01-1.69)

 

Self-efficacy for exercise (ESES, 6-60)a   Highest tertile vs lowest tertile

0.53 (0.38-0.76)

0.87 (0.63-1.19)

aHigh values indicate worse health HEPA = Health-enhancing physical activity VAS = Visual analogue scale HAQ = Stanford Health Assessment Questionnaire EuroQoL = Euro quality of life ESES = Exercise self-efficacy scale  


Disclosure: C. H. Opava, None; A. Björk, None; A. B. Dufour, None; B. Nordgren, None; I. Demmelmaier, None.

To cite this abstract in AMA style:

Opava CH, Björk A, Dufour AB, Nordgren B, Demmelmaier I. Trajectories and Predictors of Fear-Avoidance in Persons with Rheumatoid Arthritis. a Longitudinal Observational Study [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/trajectories-and-predictors-of-fear-avoidance-in-persons-with-rheumatoid-arthritis-a-longitudinal-observational-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trajectories-and-predictors-of-fear-avoidance-in-persons-with-rheumatoid-arthritis-a-longitudinal-observational-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology